Prevention of lymphoedema after axillary clearance by early external compression: a multicentre randomised interventional treatment trial

niversity Hospital of South Manchester (UK)0 个研究点目标入组 270 人开始时间: 2010年10月28日最近更新: 2020年8月3日

适应症

试验速览

暂无简介。

•1. Women aged 18 - 90 years
•2. Early breast cancer (no evidence of metastatic disease by local screening procedures), scheduled to undergo axillary node clearance
•3. Consented to pre-surgical arm measurements by perometer and develop arm volume increases of 4 - 8.9% within 6 months after surgery
•4. Willing to attend for follow-up visits per the trial schedule
•5. Written informed consent to enter the PLACE trial

•1. Any patients with no pre-surgical baseline measurements
•2. Known distant metastasis
•3. Inoperable breast cancer (T4 category or distant metastasis)
•4. Node negative not undergoing axillary clearance
•5. Previous axillary radiotherapy
•6. Past history of breast/chest wall radiotherapy
•7. Previous axillary clearance, either unilateral or bilateral
•8. Participation in another clinical trial of local therapy that may affect the results obtained in this study
•9. Pregnancy

发起方

niversity Hospital of South Manchester (UK)